• Fri, August 9, 2024
Carl Byrnes Maintained (BLFS) at Buy with Increased Target to $28 on, Aug 9th, 2024
Carl Byrnes of Northland Capital Markets, Maintained "BioLife Solutions, Inc." (BLFS) at Buy with Increased Target from $26 to $28 on, Aug 9th, 2024.
Carl has made no other calls on BLFS in the last 4 months.
There are 2 other peers that have a rating on BLFS. Out of the 2 peers that are also analyzing BLFS, 0 agree with Carl's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Carl
- Steven Mah of "TD Cowen" Maintained at Strong Buy with Increased Target to $26 on, Wednesday, July 17th, 2024
- Robert Wasserman of "Benchmark" Upgraded from Hold to Strong Buy and Held Target at $25 on, Monday, May 13th, 2024
